Event

Separate registration required.

This course provides an in-depth discussion of the steps needed to successfully implement patient-reported outcomes (PRO) measurement within the drug development program to generate data to support patient-centered value messages. Formulation of a successful PRO strategy requires an understanding of PRO instrument selection, psychometric evaluation, data capture, and interpretation to negotiate regulatory, reimbursement, and market access drug development hurdles. Judging PRO instrument quality and appropriateness can be challenging.

The course will present the key elements to consider at each step in reviewing and selecting PRO measures and determining the need for new instruments. In addition, participants will gain a better understanding of regulatory expectations for qualitative and quantitative evidence to support the quality of PRO measures and aspects to consider when interpreting meaningful change. The course will include interactive discussions of PRO success stories and common pitfalls to watch out for during PRO implementation in clinical trial programs.

Participants will gain the knowledge and skills required to take on a more active and confident role in the PRO strategy and implementation process.

PREREQUISITE: This course assumes that participants will have a basic knowledge of key PRO-related concepts (eg, health-related quality of life, symptoms, impacts, a general knowledge of the PRO development steps, and a working knowledge of PRO measurement within clinical programs.)

Principal Scientist

RTI Health Solutions

Succasunna, NJ, USA

Director, Patient-Centered Outcomes Assessment

RTI Health Solutions

Manchester, England, UK

Director

Psychometrics, Patient-Centered Outcomes Assessment

RTI Health Solutions

Durham, NC, USA

European Head, Patient-Centered Outcomes Assessment

RTI Health Solutions

Manchester, England, UK

Senior Psychometrician, Patient-Centered Outcomes Assessment

RTI Health Solutions

Bend, OR, USA